Artemisinin-Naphthoquine versus Artemether-Lumefantrine for Uncomplicated Malaria in Papua New Guinean Children: An Open-Label Randomized Trial

Artemisinin-Naphthoquine versus Artemether-Lumefantrine for Uncomplicated Malaria in Papua New Guinean Children: An Open-Label Randomized Trial

In a randomized controlled trial Tim Davis and colleagues investigate Artemisinin-naphthoquine versus artemether-lumefantrine for the treatment of P. falciparum and P. vivax malaria.

Bibliographic Details
Main Authors:	Laman, Moses, Moore, Brioni R., Benjamin, John M., Yadi, Gumul, Bona, Cathy, Warrel, Jonathan, Kattenberg, Johanna H., Koleala, Tamarah, Manning, Laurens, Kasian, Bernadine, Robinson, Leanne J., Sambale, Naomi, Lorry, Lina, Karl, Stephan, Davis, Wendy A., Rosanas-Urgell, Anna, Mueller, Ivo, Siba, Peter M., Betuela, Inoni, Davis, Timothy M. E.
Format:	Online
Language:	English
Published:	Public Library of Science 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280121/

Similar Items

Artemisinin-Naphthoquine versus Artemether-Lumefantrine for Uncomplicated Malaria in Papua New Guinean Children: An Open-Label Randomized Trial
by: Laman, M., et al.
Published: (2014)

Artemether-lumefantrine versus artemisinin-naphthoquine in Papua New Guinean children with uncomplicated malaria: A six months post-treatment follow-up study
by: Laman, M., et al.
Published: (2015)

Artemether-lumefantrine versus artemisinin-naphthoquine in Papua New Guinean children with uncomplicated malaria: a six months post-treatment follow-up study
by: Laman, Moses, et al.
Published: (2015)

Comparison of three methods for detection of gametocytes in Melanesian children treated for uncomplicated malaria
by: Karl, Stephan, et al.
Published: (2014)

Population Pharmacokinetics of Artemether, Lumefantrine, and Their Respective Metabolites in Papua New Guinean Children with Uncomplicated Malaria
by: Salman, S., et al.
Published: (2011)

Temporal changes in Plasmodium falciparum anti-malarial drug sensitivity in vitro and resistance-associated genetic mutations in isolates from Papua New Guinea
by: Koleala, Tamarah, et al.
Published: (2015)

Temporal changes in Plasmodium falciparum anti-malarial drug sensitivity in vitro and resistance-associated genetic mutations in isolates from Papua New Guinea
by: Koleala, T., et al.
Published: (2015)

Meningeal inflammation increases cerebrospinal fluid artemether concentrations in Papua New Guinean children treated with intramuscular artemether
by: Manning, L., et al.
Published: (2011)

Comparison of an assumed versus measured leucocyte count in parasite density calculations in Papua New Guinean children with uncomplicated malaria
by: Laman, Moses, et al.
Published: (2014)

Risk factors for Plasmodium falciparum and Plasmodium vivax gametocyte carriage in Papua New Guinean children with uncomplicated malaria
by: Karl, S., et al.
Published: (2016)

Comparison of an assumed versus measured leucocyte count in parasite density calculations in Papua New Guinean children with uncomplicated malaria
by: Laman, M., et al.
Published: (2014)

Severe Anemia in Papua New Guinean Children from a Malaria-Endemic Area: A Case-Control Etiologic Study
by: Manning, Laurens, et al.
Published: (2012)

Comparison of three methods for detection of gametocytes in Melanesian children treated for uncomplicated malaria
by: Karl, S., et al.
Published: (2014)

Artemisinin-Naphthoquine Combination Therapy for Uncomplicated Pediatric Malaria: a Pharmacokinetic Study
by: Batty, Kevin, et al.
Published: (2012)

Rapid Antigen Detection Tests for Malaria Diagnosis in Severely Ill Papua New Guinean Children: A Comparative Study Using Bayesian Latent Class Models
by: Manning, Laurens, et al.
Published: (2012)

Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: A tolerability, safety, and preliminary efficacy study
by: Benjamin, J., et al.
Published: (2012)

Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean women
by: Benjamin, J., et al.
Published: (2015)

Features and Prognosis of Severe Malaria Caused by Plasmodium falciparum, Plasmodium vivax and Mixed Plasmodium Species in Papua New Guinean Children
by: Manning, Laurens, et al.
Published: (2011)

Population Pharmacokinetics and Pharmacodynamics of Lumefantrine in Young Ugandan Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria
by: Tchaparian, Eskouhie, et al.
Published: (2016)

Quality Assessment of Artemether-Lumefantrine Samples and Artemether Injections Sold in the Cape Coast Metropolis
by: Prah, James, et al.
Published: (2016)

The Use of Artemether-Lumefantrine for the Treatment of Uncomplicated Plasmodium vivax Malaria
by: Bassat, Quique
Published: (2011)

A cost-effectiveness analysis of artemether lumefantrine for treatment of uncomplicated malaria in Zambia
by: Chanda, Pascalina, et al.
Published: (2007)

Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Malaria: A Randomized Trial
by: Kamya, Moses R, et al.
Published: (2007)

The magnitude and trend of artemether-lumefantrine stock-outs at public health facilities in Kenya
by: Sudoi, Raymond K, et al.
Published: (2012)

Possible Clinical Failure of Artemether-Lumefantrine in an Italian Traveler with Uncomplicated Falciparum Malaria.
by: Repetto, Ernestina C., et al.
Published: (2011)

Implementation of artemether-lumefantrine treatment policy for malaria at health facilities in Tanzania
by: Mugoyela, V, et al.
Published: (2011)

Pharmacovigilance of artemether-lumefantrine in pregnant women followed until delivery in Rwanda
by: Rulisa, Stephen, et al.
Published: (2012)

Population pharmacokinetics of mefloquine, piperaquine and artemether-lumefantrine in Cambodian and Tanzanian malaria patients
by: Staehli Hodel, Eva Maria, et al.
Published: (2013)

Formulation, process development and evaluation of artemether and lumefantrine soft gelatin capsule
by: Patel, A., et al.
Published: (2012)

Safety of artemether-lumefantrine exposure in first trimester of pregnancy: an observational cohort
by: Mosha, Dominic, et al.
Published: (2014)

Efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Nepal
by: Prakash Ghimire, et al.
Published: (2018-08-01)

Plasmodium falciparum gametocyte dynamics after pyronaridine–artesunate or artemether–lumefantrine treatment
by: Johanna M. Roth, et al.
Published: (2018-06-01)

Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children.
by: Liusheng Huang, et al.

Monitoring the efficacy of artemether-lumefantrine for the treatment of uncomplicated malaria in Malawian children
by: Dambe, Rosalia, et al.
Published: (2015)

A dietary strategy for the management of artemether-lumefantrine-induced cardiovascular and renal toxicity
by: Asiedu-Gyekye, Isaac Julius, et al.
Published: (2016)

Therapeutic efficacy of artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Benin
by: Ogouyèmi-Hounto, Aurore, et al.
Published: (2016)

A systematic review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmission
by: Makanga, Michael
Published: (2014)

Exposure to artemether-lumefantrine (Coartem®) in first trimester pregnancy in an observational study in Zambia
by: Manyando, Christine, et al.
Published: (2015)

Quality and stability of artemether-lumefantrine stored under ambient conditions in rural Mali
by: Gitua, John, et al.
Published: (2014)

Treatment of Asymptomatic Carriers of Plasmodium falciparum with Artemether–Lumefantrine: Impact on the Prevalence of Anemia
by: Tiono, Alfred B., et al.
Published: (2013)